Press Center: Articles

The article proposes classifying the models of discharging a citizen from obligations based on the legal circumstance that is recognized as sufficient to terminate the compulsory enforceability of the remaining debt. Three basic logics are distinguished: procedural-discharge, payment-disciplinary, and evaluative-selective. It is shown that they describe different grounds for discharge and can be combined within a single legal order. The Russian construct is qualified as a procedural-discharge model with a restrictive-filtering mechanism: completion of the procedure prescribed by law constitutes the general ground for discharge, while bad faith and other disqualifying circumstances act as exceptions. This approach allows for distinguishing between rehabilitation and restructuring, explaining the statistical dominance of property realization, and determining the limits of judicial discretion in the application of Art. 213.28 of the Bankruptcy Law¹.

Seed traceability in Russia has made the illegal reproduction of varieties visible. But the right holder will receive money only within the limits fixed in the license agreement. Which mistakes in contracts leave breeders without royalties (license payments) and how to protect a variety for the entire term of its protection — in the author's column by Boris Malakhov, managing partner of the law firm Lidings.

The article provides an algorithm for recovering the full value of assets instead of the price difference when a transaction is challenged due to inadequate consideration.

A change of managing partner at a law firm is rarely just a personnel decision – more often, it is a test of the sustainability of the business model and the maturity of the partnership. Lidings partners Andrey Zelenin and his successor as managing partner, Boris Malakhov, argue that their transition was neither a crisis nor a reboot, but rather a confirmation of the viability of the chosen governance structure – one that maintains trust within the team and carefully adapts to a changing market.

India has long and firmly established itself as the ‘pharmacy of the world’, as the country produces a fifth of all generics and provides affordable medicines to millions of people across the globe. However, India is now transitioning from copying innovative molecules to creating them. Amid the restructuring of global supply chains and strategic rapprochement with Russia, India is becoming both a battleground for fierce patent wars and a unique laboratory for joint research. How can Russian pharmaceutical companies establish intellectual property protection in a jurisdiction where the balance between the interests of pharmaceutical giants and the affordability of medicines for the population is enshrined in law? Boris Malakhov and Natalya Thotahewage analyse the key features of patenting and the prospects for technological alliances between Moscow and Delhi.